TAS-102 is a novel oral combination drug that consists of an antineoplastic thymidine-based nucleoside analog, trifluorothymidine, and a potent thymidine phosphorylase inhibitor, tipiracil, in a 1:0.5 molar ratio.
Molecular Weight:
435.76
CAS Number:
[733030-01-8]
Formula:
C10H11F3N2O5 . 1/2C9H11ClN4O2 . 1/2HCl
* VAT and and shipping costs not included. Errors and price changes excepted